Publications "Bär, Sofia I."
Jump to: Article in a journal | Doctoral thesis Number of items: 6. Article in a journal
Bär, Sofia I. ; Pradhan, Rohan ; Biersack, Bernhard ; Nitzsche, Bianca ; Höpfner, Michael ; Schobert, Rainer:
New chimeric HDAC inhibitors for the treatment of colorectal cancer. In: Archiv der Pharmazie. Vol. 356 (2023) Issue 2 . - 2200422. ISSN 1521-4184 DOI der Verlagsversion: https://doi.org/10.1002/ardp.202200422
Bär, Sofia I. ; Biersack, Bernhard ; Schobert, Rainer:
3D cell cultures, as a surrogate for animal models, enhance the diagnostic value of preclinical in vitro investigations by adding information on the tumour microenvironment : a comparative study of new dual-mode HDAC inhibitors. In: Investigational New Drugs. Vol. 40 (2022) Issue 5 . - pp. 953-961. ISSN 1573-0646 DOI der Verlagsversion: https://doi.org/10.1007/s10637-022-01280-0
Kober, Luisa ; Schleser, Sebastian W. ; Bär, Sofia I. ; Schobert, Rainer:
Revisiting the anticancer properties of phosphane(9-ribosylpurine-6-thiolato)gold(I) complexes and their 9H-purine precursors. In: JBIC Journal of Biological Inorganic Chemistry. Vol. 27 (2022) Issue 8 . - pp. 731-745. ISSN 1432-1327 DOI der Verlagsversion: https://doi.org/10.1007/s00775-022-01968-x
Bär, Sofia I. ; Gold, Madeleine ; Schleser, Sebastian W. ; Rehm, Tobias ; Bär, Alexander ; Köhler, Leonhard ; Carnell, Lucas R. ; Biersack, Bernhard ; Schobert, Rainer:
Guided Antitumoural Drugs : (Imidazol-2-ylidene)(L)gold(I) Complexes Seeking Cellular Targets Controlled by the Nature of Ligand L. In: Chemistry : a European Journal. Vol. 27 (2021) Issue 15 . - pp. 5003-5010. ISSN 1521-3765 DOI der Verlagsversion: https://doi.org/10.1002/chem.202005451
Soliga, Kevin J. ; Bär, Sofia I. ; Oberhuber, Natalie ; Zeng, Haoxuan ; Schrey, Hedda ; Schobert, Rainer:
Synthesis and Bioactivity of Ancorinoside B, a Marine Diglycosyl Tetramic Acid. In: Marine Drugs. Vol. 19 (2021) Issue 10 . - No. 583. ISSN 1660-3397 DOI der Verlagsversion: https://doi.org/10.3390/md19100583 Doctoral thesis
Bär, Sofia I.:
Präklinische Studien neuer multimodaler, antitumoraler Hybridwirkstoffe mittels klassischer 2D- und realitätsnäherer 3D-Tumorzellkulturassays. Bayreuth , 2023 . - V, 293 P. ( Doctoral thesis, 2023 , University of Bayreuth, Faculty of Biology, Chemistry and Earth Sciences) |